Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 361 - 380 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18 19  20  21  22  23  24  25 »
Reset 

Mission Bay Capital Announces $60 Million Fund III

SAN FRANCISCO, Sept. 16, 2019 /PRNewswire/ -- Mission Bay Capital, an early-stage life-science venture capital firm investing... Read more ››

By: PR Newswire Association LLC. - 16 Sep 2019
Related companies:  Mission Bay Capital | QB3/Mission Bay Capital

CartilaGen Wins Pappajohn Iowa Entrepreneurial Venture Competition and Receives $25,000 Award

DES MOINES, Iowa, Sept. 16, 2019 /PRNewswire/ -- CartilaGen, Inc., a medical technology startup spun out from the University of Iowa's Department of Orthopedics and Rehabilitation, announced today that the company has been named the second-place winner of the 2019 Pappajohn Iowa Entrepreneurial... Read more ››

By: PR Newswire Association LLC. - 16 Sep 2019

Saint Francis Veterinary Center of South Jersey Wins Accredited Practice of the Year, Named a Finalist for Unprecedented Third Time

WOOLWICH TOWNSHIP, N.J., Sept. 16, 2019 /PRNewswire/ -- Saint Francis Veterinary Center of South Jersey... Read more ››

By: PR Newswire Association LLC. - 16 Sep 2019

Kas Subramanian, PhD Joins Applied BioMath, LLC as Senior Director of Preclinical Modeling

CONCORD, Mass., Sept. 16, 2019 /PRNewswire/ -- Applied BioMath (www.appliedbiomath.com), the industry-leader in... Read more ››

By: PR Newswire Association LLC. - 16 Sep 2019
Related companies:  Applied BioMath, LLC

China Prothrombin Complex Concentrate Market to 2023: Disease Incidences, Supply/Demand, Competition, Prices, Market Prospects

DUBLIN, Sept. 16, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 16 Sep 2019

SillaJen Defending Position Relating to Recent Sale of Stock by Employee

SEOUL, South Korea and SAN FRANCISCO, Sept. 16, 2019 /PRNewswire/ -- SillaJen, Inc., (KOSDAQ:215600), a clinical-stage, biotherapeutics company focused on the development of oncolytic immunotherapy products for cancer, today affirmed that the company is fully cooperating with the Joint Securities... Read more ››

By: PR Newswire Association LLC. - 16 Sep 2019

Human Factors and Usability Engineering in the Development of Drug Delivery Products Workshop: Requirements of IEC 62366 and FDA Human Factors Guidelines - London, United Kingdom - October 2-3, 2019

DUBLIN, Sept. 16, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 16 Sep 2019

Europe Drug Delivery Systems Market Report 2018-2019 & 2027

DUBLIN, Sept. 16, 2019 /PRNewswire/ -- The Read more ››

By: PR Newswire Association LLC. - 16 Sep 2019

Valens Becomes First Third Party Processor to Enter Strategic Agreement with Shoppers Drug Mart to Supply Cannabis Oil Products

KELOWNA, BC, Sept. 16, 2019 /PRNewswire/ - Valens GroWorks Corp. (TSXV: VGW) (OTC: VGWCF) (the "Company" or "Valens"), a vertically integrated provider of industry leading extraction products and services; including a diverse suite of extraction methodologies, next... Read more ››

By: PR Newswire Association LLC. - 16 Sep 2019
Related companies:  Valens GroWorks Corp.

Nextleaf Solutions Announces Supply Agreement with BevCanna Enterprises

Two proudly BC Based companies well positioned for early market leadership within infused product landscape.

Read more ››
By: PR Newswire Association LLC. - 16 Sep 2019

Neovasc Announces Changes to its Board of Directors

Norman Radow, Managing Partner at Strul Medical Group, Joins Company's Board

Read more ››
By: PR Newswire Association LLC. - 16 Sep 2019
Related companies:  Neovasc Inc.

Syqe Enters Into Distribution Agreement With TerrAscend to Bring Revolutionary Medical Cannabis Treatment to Canada

Leading pharma-tech company inks deal with TerrAscend to bring the first and only inhalation device that can deliver safe, precise and consistent dosages of medical cannabis to the Canadian market

Read more ››
By: PR Newswire Association LLC. - 16 Sep 2019
Related companies:  TerrAscend Corp.

Mindmed Acquires Opioid Addiction Drug Candidate Based on the Natural Psychedelic Ibogaine

Company aims to discover and develop psychedelic inspired medicines

Read more ››
By: PR Newswire Association LLC. - 16 Sep 2019
Related companies:  Mind Alive Inc. | Mind the Byte

Curetis Group Subsidiary Ares Genetics Signs R&D and Option Agreement with Leading Global IVD Corporation

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Curetis AG

Lundbeck to acquire Alder BioPharmaceuticals – a company committed to transforming migraine treatment and prevention – in a transaction valued at up to USD 1.95 billion net of cash

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Alder BioPharmaceuticals, Inc.

Cergentis appoints new board

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019

Helsinn and Mundipharma China Pharmaceutical jointly announce NMPA’s approval of the oral formulation of Akynzeo® in China

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019

Roche ranked as one of the most sustainable healthcare companies in the Dow Jones Sustainability Indices for the eleventh year running

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  F. Hoffmann-La Roche AG (Venture Fund) | Hoffmann-La Roche Limited (Roche Canada) | F. Hoffmann-La Roche AG | Hoffmann-La Roche Ltd. (Edmonton)

Medtronic and Novo Nordisk Enter Agreement to Provide Integrated Digital Solutions for People with Diabetes

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Medtronic Plc

Digirad Corporation Announces Preliminary Guidance for 2020

Read more ››
By: Nasdaq / GlobenewsWire - 16 Sep 2019
Related companies:  Digirad Corporation
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18 19  20  21  22  23  24  25 »
to the top ↑